2024 ASCO China Voice: China’s TIL therapy – GC203: A Powerful Strike Against Ovarian Cancer with an 83.3% Disease Control Rate
2024 ASCO China Voice: China’s TIL therapy makes a grand debut, targeting ovarian cancer. **GC203: A Powerful Strike Against Ovarian Cancer with an 83.3% Disease Control Rate** TIL therapy Ov...